Co-founder and CEO
Dr. Andreas Persidis is the President of the Hellenic BioCluster (HBio) and co-founder and CEO of Biovista Inc. He is a member (rapporteur) of the H2020 Expert Advisory Group on Innovation for SMEs (DG RTD), an expert reviewer and evaluator for the European Commission, the Austrian (FIT-IT) and Greek government, has managed on behalf of the European Commission a roadmap study on systematic innovation, and has advised the Greek government (GSRT) on innovation strategy and research priorities in the areas of IT and the life sciences. He has been a delegation member of EU-China, EU-Brazil and EU-Thailand cluster collaboration meetings as well as a member of the Greek business delegation to Israel.
Dr. Persidis has managed technology development teams at European corporations in the engineering, software and telecoms fields. He has conducted research in the fields of machine learning and applied Artificial Intelligence, which has led to the launch of multiple international research projects. He has also published extensively in international journals, co-authored book chapters in systematic drug repositioning and is an invited speaker at forums on drug repositioning, innovation and export oriented high-tech companies. Dr. Persidis is the co-inventor and holder of 5 patents on repurposed drugs and a «Top 100 AI Leader in Drug Discovery and Advanced Healthcare”.